Resuscitation strategies incorporating peripheral perfusion targets in septic shock: A systematic review and meta-analysis of randomized controlled trials
In brief
Peripheral-perfusion targets cut early fluids by 265 mL, without proven survival gain
Across five randomized trials involving 2,180 patients with septic shock, strategies using peripheral perfusion targets reduced fluid given in the first 6 to 8 hours by about 265 mL. They did not show a significant mortality benefit or improve other major outcomes; low-certainty evidence and differences between treatment protocols leave the effects of monitoring itself uncertain.
- Journal
- Journal of critical care (Q1)
- Published
- 13 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Erlei Joslan Santos Bispo, Lucyana de Melo Baptista, Cristiano Berardo Carneiro da Cunha, Verônica Soares Monteiro
- PMID
- 43025024
- DOI
- 10.1016/j.jcrc.2026.155829
Why clinicians should know about it
- Picked for Critical Care and Intensive Care Medicine (paper of the day, 15 November 2026): Systematic review evaluates perfusion-targeted resuscitation in septic shock
- Picked for Emergency Medicine (top studies of the week, 15 November 2026): Randomized-trial evidence for septic shock resuscitation targets
Abstract
PURPOSE: Resuscitation strategies incorporating peripheral perfusion targets (RSIPPT) have emerged as promising tools in septic shock. However, whether they improve clinically relevant outcomes remains uncertain. We aimed to evaluate whether these strategies reduce 28/30-day mortality and improve other clinical outcomes compared with usual care. METHODS: A systematic review and meta-analysis of randomized controlled trials (RCTs) using a random-effects model was conducted. Electronic searches of PubMed, EMBASE, and CENTRAL were performed through May 27, 2026 (PROSPERO CRD420261400115). The RoB 2 and GRADE tools were used for assessment of risk of bias and certainty of evidence (CoE), respectively. RESULTS: Five RCTs involving 2180 patients with septic shock were included. Compared with conventional strategies, RSIPPT were not associated with significant differences in 28/30-day mortality (four RCTs; RR 0.92, 95% CI 0.78-1.09; I2 = 10%; moderate CoE) or 90-day mortality (three RCTs; RR 0.94, 95% CI 0.83-1.05; I2 = 0%; low CoE). However, RSIPPT were associated with fluid reduction during the first 6-8 h of resuscitation (three RCTs; MD -264.53 mL, 95% CI -425.28 to -103.77; I2 = 1%; low CoE). No significant differences were observed in intensive care unit or hospital length of stay, organ dysfunction, vasopressor-free days, ventilator-free days, or renal replacement therapy-free days. CONCLUSION: In early septic shock, RSIPPT were associated with a modest reduction in resuscitation fluid during the first 6-8 h. A mortality reduction was not demonstrated, although clinically important benefit or harm cannot be excluded. Differences in intervention algorithms and comparators limit attribution of these findings to peripheral perfusion monitoring itself.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.